Patrick C. M. Vermote

Oral antiallergic activity in ascaris hypersensitive dogs: A study of known antihistamines and of the new compounds ramastine (R 57 959) and levocabastine (R 50 547)

F. Awouters, Jozef Vermeire, Frans Smeyers et al. · Drug Development Research · 1986 · 96 citations

Antiallergic Effectiveness, Antiparasitic Agent, Allergy Medicine +21

Discovery of a New Series of Centrally Active Tricyclic Isoxazoles Combining Serotonin (5-HT) Reuptake Inhibition with α₂-Adrenoceptor Blocking Activity

José Ignacio Andrés, Jesús Alcázar, José Manuel Alonso Segura et al. · Journal of Medicinal Chemistry · 2004 · 49 citations · Full text

Psychopharmacology, Pharmacotherapy, New Series +16

Pharmacological validation of ritanserin and risperidone in the drug discrimination test procedure in the rat

Theo Meert, Patrick L. A. J. De Haes, Patrick C. M. Vermote et al. · Drug Development Research · 1990 · 39 citations

Psychotropic Medication, Psychopharmacology, Pharmacotherapy +23

Pharmacological Profile of (2 R-trans)-4-[1-[3,5-bis(Trifluoromethyl)benzoyl]-2-(phenylmethyl)-4-piperidinyl]-N-(2,6-dimethylphenyl)-1-acetamide (S)-Hydroxybutanedioate (R116301), an Orally and Centrally Active Neurokinin-1 Receptor Antagonist

Anton A. H. P. Megens, D. Ashton, Jef Vermeire et al. · Journal of Pharmacology and Experimental Therapeutics · 2002 · 26 citations